Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
hydrocodone bitartrate/chlorpheniramine maleate (Vituz)
print preview
bookmark
share with colleague
General Information
Company
Pernix Therapeutics Holdings Inc.
Description
Oral combination of hydrocodone bitartrate, an antitussive, and chlorpheniramine maleate, a histamine H1 receptor (HRH1) antagonist
Molecular Target
Histamine H1 receptor (HRH1)
Mechanism of Action
Histamine H1 receptor antagonist
Latest Stage of Development
Approved
Indication
Cough
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy